arrow
S

Sang-Hyun Ihm

the catholic university of korea bucheon st mary's hospital
H指数:30
被引数:3,493

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of a Single-Pill Triple Combination of Valsartan, Amlodipine, and Chlorthalidone in Patients With Essential Hypertension Inadequately Controlled on Dual Therapy With Valsartan and Amlodipine: A Randomized, Double-Blind, Multicenter, Phase 3 Trial

缬沙坦、氨氯地平和氯噻酮单药三联组合在未充分控制血压的缬沙坦和氨氯地平双药治疗原发性高血压患者中的疗效与安全性:一项随机、双盲、多中心、III期试验

2026-09-300
OAAI
Aldosterone-renin ratio and plasma renin activity as biomarkers for treatment response in resistant hypertension

醛固酮-肾素比值和血浆肾素活性作为耐药性高血压治疗反应的生物标志物

2026-08-190
PRE
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized; Double-Blind; Multicenter; Phase III Study

缬沙坦/吲达帕胺联合疗法与缬沙坦单药疗法在未充分响应缬沙坦30 mg治疗的原发性高血压患者中的疗效与安全性比较(FINEDUO研究):一项随机、双盲、多中心、III期研究

2026-05-150
OAAI
The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension

胰高血糖素样肽-1受体激动剂(GLP1-RAs)在代谢综合征合并高血压患者管理中的作用:韩国高血压学会立场文件

2024-09-010
OAAI
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy
2024-06-010
PRE
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets

在收缩压达标的情况下,治疗期间升高的舒张压与心血管结局的关系

2022-01-014
OAAI